Sagimet Biosciences (STU:0O2) EV-to-Revenue: (As of Jul. 11, 2026)

Sagimet Biosciences  (STU:0O2) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sagimet Biosciences's PS Ratiofor today is calculated as:

Sagimet Biosciences's share price for today is €6.44.
Sagimet Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagimet Biosciences EV-to-Revenue Related Terms

The historical data trend for Sagimet Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagimet Biosciences EV-to-Revenue Chart

Sagimet Biosciences Quarterly Data
	Dec20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-Revenue	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

STU:0O2 vs EDIT, AUTL, FBRX: EV-to-Revenue Comparison

For the Biotechnology subindustry, Sagimet Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sagimet Biosciences EV-to-Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagimet Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sagimet Biosciences's EV-to-Revenue falls into.

Sagimet Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sagimet Biosciences's EV-to-Revenue for today is calculated as:

Sagimet Biosciences's current Enterprise Value is €307.88 Mil.
Sagimet Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagimet Biosciences Business Description